NFKB2 and cholangiocarcinoma: Consistent with our hypothesis, Seubwai et al. also reported increased expression of NF-κB, including p52 subunits, in CCA patient tissues, and that inhibition of NF- κB expression reduces cell proliferation and tumor size in CCA-inoculated mice30.